Social Media Ideas for Regenerative Therapies

Regenerative Medicine Innovations Shaping The Future Of Healthcare

Healthcare looks different today than it did a decade ago. Patients now expect treatments that support recovery, reduce long-term complications, and improve quality of life. Resear...

The State of Stem Cell Therapies

First generation stem cell therapies that use a variety of cell sources and protocols are widely used in the medical tourism industry. A more limited set of such therapies are used...

Considering Replacement Based Therapies to Treat Aging

How far can one go, practically speaking, and in the relatively near future, to develop therapies to treat aging based on replacement of worn parts? Some forms of replacement thera...

<![CDATA[Steer Bio Targets Lymphedema with Regenerative Cell Therapy Platform]]>

Could Tissue Restoration Be the Next Step in Regenerative Aesthetics?

Research into the extracellular matrix is exploring new approaches to restoring soft tissue, with potential applications ranging from facial rejuvenation to post-weight-loss restor...

Denver Regenerative Medicine Publishes Patient-Education Materials Defining "Rejuvenation Therapy"

Regenerative Medicine in the Bronze Age: MSCs and MSC-EVs Leading the Way

The field of regenerative medicine is gaining momentum. Mesenchymal stem cells (MSCs) remain central to this field, with expanding applications as direct therapies and as producers...

Timing Regenerative Signals Determines Healing Outcomes After Injury

Medicine has long aimed to deliver the right therapeutic signals to the right tissue at the right moment. New University of Oregon research suggests that regenerative outcomes may...

Joseph Spine Institute Announces New Regenerative Therapy Center, Offering Advanced Adipose-Derived Cell and PRP Therapi...

TAMPA, Fla., Sept. 3, 2026 /PRNewswire/ — Joseph Spine Institute, a nationally recognized leader in advanced spine care and minimally invasive…

Proposing the Synergy of Therapeutic Plasma Exchange and Partial Epigenetic Reprogramming

It seems a little early in the development of partial epigenetic reprogramming as a class of therapy to be thinking about which of the other approaches to aging it can best be comb...

How Spray-On Skin Cells Restore Form and Function After Wound Closure

Autologous Spray-On Skin Cells are expanding what's possible in reconstructive surgery. By reducing donor skin requirements and supporting faster, more natural healing, the technol...

Chinese stem cell therapy reverses heart failure in 90% of patients in landmark trial

A hospital in east China has used reprogrammed stem cells to treat severe heart failure, with 90 per cent of patients showing significant recovery in heart function after the novel...

Exosome Therapy Reduces Scarring and Heart Failure Following a Heart Attack

The heart regenerates poorly in comparison to other tissues, and the maladaptive inflammation that occurs following a heart attack does not help the situation. Fibrosis and scarrin...

Should Stem Cell Therapies Be Regulated as Drugs? This Biotech Company Is Taking the FDA to Court.

The FDA says it can't license Regenative Lab's overseas sales today because it might change its regulations tomorrow. Now, the company is suing.

CAR T-Cell Therapy Puts Severe Rheumatoid Arthritis Into Remission in First Clinical Trial

Researchers at Charité report promising results from the first CAR T-cell trial for treatment-refractory rheumatoid arthritis, with all six patients improving and three achieving s...

Could a Growth Factor Help Complex Wounds Heal Faster After Skin Cancer Surgery?

Enrollment is complete in a phase 2 trial investigating the use of pure PDGF as an adjunctive therapy for complex surgical wounds following skin cancer excision.

Embedding Regulatory Strategy in Cell and Gene Therapy Development

In this GEN webinar, experts from Rose BioSolutions, a CDMO and Cell Solutions organization formed from Charles River Laboratories’ businesses, will discuss how integrating regulat...

Regulatory T cell reprogramming heads to trial in 2026

Most people have heard of cancer immunotherapy by now. These treatments help a patient’s own immune system recognize and attack cancer. The best-known examples are immune checkpoin...

Colorectal Cancer Targeted with Mass-Produced iPSC-Derived Allogeneic T Cells

Researchers generated off-the-shelf, mass-producible iPSC-derived allogeneic γδT cells that in a small preclinical study suppressed tumor growth in mouse colorectal cancer xenograf...

Genetic Map Opens Door to Development of New Therapies to Reverse Bone Loss

The international team of scientists identified hundreds of previously unknown genes that govern bone health and revealed cells surrounding blood vessels as one of the drivers of b...

Landmark Phase III Trial Finds Cell Therapy Slows Muscle Decline in Advanced DMD

A Phase III trial found the donor-derived cell therapy deramiocel slowed arm muscle decline in boys and young men with advanced Duchenne muscular dystrophy, with potential benefits...

Autolomous and Cellular Origins Expand Cell Therapy Manufacturing Process

The combined solution using Constellation and autoloMATE overcomes fragmentation, limited visibility, and the absence of standardized, interoperable data flows without replacing ex...

Reprogramming of Corticospinal Neurons Improves Recovery of Function in Mice Following Stroke

Rehabilitation following a stroke that causes significant loss of function is a slow, painful, and uncertain process. The concept underlying these efforts is that the brain will at...

Long-term safety of iPS spinal cord therapy confirmed in Japan

The team plans to launch an investigator-initiated clinical trial as early as next year to bring it into practical use.